Sentara Infusion Services recalls CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 I…
- Recall date
- December 27, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0281-2023
- FDA classification
- Class II
- Brand / firm
- Sentara Infusion Services
- Sold / distributed
- Dispensed to Patients Nationwide.
Why it was recalled
Lack of sterility assurance
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
Get recall alerts
Free email alert whenever Sentara Infusion Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Infusion Services